Perrigo Income Statement
PRGO / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Perrigo reported $4.3B in revenue and $1.4B in net loss for FY2025. Revenue has grown at a 2.3% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3B | $4.4B | $4.7B | $4.1B | $3.9B | $4.1B | $4.9B | $5.3B | $4.9B | $5.3B | $4.2B | $1.8B | $3.9B | $3.2B |
| Cost of Revenue | $2.8B | $2.8B | $3.0B | $2.6B | $2.4B | $2.6B | $3.0B | $3.2B | $3.0B | $3.2B | $2.6B | $1.2B | $2.5B | $2.1B |
| Gross Profit | $1.5B | $1.5B | $1.7B | $1.5B | $1.4B | $1.5B | $2.0B | $2.1B | $2.0B | $2.1B | $1.6B | $673.8M | $1.5B | $1.1B |
| SG&A Expense | $435.9M | $468.0M | $522.3M | $478.5M | $476.5M | $478.5M | $461.1M | $452.2M | $461.1M | $452.2M | $385.3M | $165.6M | $411.3M | $224.4M |
| R&D Expense | $95.4M | $112.2M | $122.5M | $121.7M | $119.2M | $121.7M | $167.7M | $184.0M | $167.7M | $184.0M | $187.8M | $89.8M | $152.5M | $105.8M |
| Operating Income | -$1.1B | $112.9M | $151.9M | $265.2M | $174.7M | $265.2M | $598.2M | -$2.0B | $598.2M | -$2.0B | $672.5M | $289.7M | $571.4M | $569.2M |
| Interest Expense | - | - | - | -$127.7M | -$117.5M | - | -$168.1M | -$216.6M | -$168.1M | - | - | - | -$103.5M | - |
| Income Tax | $104.4M | $80.0M | -$3.9M | -$38.3M | -$10.7M | -$38.3M | $160.5M | -$835.5M | $160.5M | -$835.5M | $124.2M | $29.4M | $70.8M | $119.0M |
| Net Income | -$1.4B | -$171.8M | -$12.7M | -$162.6M | $146.1M | -$162.6M | $119.6M | -$4.0B | $119.6M | -$4.0B | $136.1M | $180.6M | $232.8M | $401.6M |
| EPS (Basic) | -$0.09 | -$1.04 | -$0.52 | -$1.20 | $1.07 | $0.95 | $0.84 | -$28.01 | $0.84 | $2.02 | $4.71 | $4.31 | $2.02 | $4.31 |
| EPS (Diluted) | -$0.09 | -$1.04 | -$0.52 | -$1.19 | $1.07 | $0.95 | $0.84 | -$28.01 | $0.84 | $2.01 | $4.68 | $4.27 | $2.01 | $4.27 |
| Shares Outstanding | 136.5M | 135.5M | 134.7M | 137.2M | 136.5M | 138.3M | 142.6M | 143.3M | 142.6M | 115.6M | 94.5M | 94.1M | 115.6M | 94.1M |
| Gross Margin | 35.1% | 35.3% | 36.1% | 36.6% | 37.0% | 36.6% | 40.0% | 38.9% | 40.0% | 38.9% | 38.9% | 36.5% | 37.1% | 34.5% |
| Operating Margin | -26.4% | 2.6% | 3.3% | 6.5% | 4.5% | 6.5% | 12.1% | -37.9% | 12.1% | -37.9% | 15.9% | 15.7% | 14.6% | 17.9% |
| Profit Margin | -33.5% | -3.9% | -0.3% | -4.0% | 3.8% | -4.0% | 2.4% | -76.0% | 2.4% | -76.0% | 3.2% | 9.8% | 5.9% | 12.7% |